Abstract
Parvovirus B19 is responsible for approximately 10% of all cases of nonimmune hydrops. An unusual case of perinatally acquired parvovirus infection in a neonate is reported who presented with nonimmune hydrops fetalis at D15 of life.
MeSH terms
-
Blood Transfusion / methods
-
Combined Modality Therapy
-
Female
-
Follow-Up Studies
-
Humans
-
Hydrops Fetalis / etiology*
-
Hydrops Fetalis / physiopathology
-
Hydrops Fetalis / therapy
-
Immunoglobulins, Intravenous / therapeutic use
-
India
-
Infant, Newborn
-
Parvoviridae Infections / complications*
-
Parvoviridae Infections / diagnosis
-
Parvovirus B19, Human / isolation & purification*
-
Rare Diseases
-
Risk Assessment
-
Severity of Illness Index
-
Treatment Outcome
-
Vitamin K / therapeutic use
Substances
-
Immunoglobulins, Intravenous
-
Vitamin K